▶ 調査レポート

遺伝子組換え蛋白医薬品の世界市場2017

• 英文タイトル:Global Recombinant Protein Drugs Sales Market Report 2017

QYResearchが調査・発行した産業分析レポートです。遺伝子組換え蛋白医薬品の世界市場2017 / Global Recombinant Protein Drugs Sales Market Report 2017 / A040100253資料のイメージです。• レポートコード:A040100253
• 出版社/出版日:QYResearch / 2017年2月14日
• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥432,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥864,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、遺伝子組換え蛋白医薬品の世界市場について調査・分析し、遺伝子組換え蛋白医薬品のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、遺伝子組換え蛋白医薬品産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。(※Sales:遺伝子組換え蛋白医薬品の販売量、Revenue:遺伝子組換え蛋白医薬品の売上高)

・遺伝子組換え蛋白医薬品市場概要
・遺伝子組換え蛋白医薬品のメーカー別販売量・メーカー別シェア
・遺伝子組換え蛋白医薬品の世界市場:種類別販売量・市場シェア
・遺伝子組換え蛋白医薬品の世界市場:用途別販売量・市場シェア
・遺伝子組換え蛋白医薬品の世界市場:地域別販売量・市場シェア
・遺伝子組換え蛋白医薬品のアメリカ市場規模
・遺伝子組換え蛋白医薬品の中国市場規模
・遺伝子組換え蛋白医薬品のヨーロッパ市場規模
・遺伝子組換え蛋白医薬品の日本市場規模
・遺伝子組換え蛋白医薬品の東南アジア市場規模
・遺伝子組換え蛋白医薬品のインド市場規模
・遺伝子組換え蛋白医薬品のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・遺伝子組換え蛋白医薬品のコスト分析・価格動向
・遺伝子組換え蛋白医薬品の産業チェーン(サプライチェーン分析)
・遺伝子組換え蛋白医薬品のマーケティング戦略・販売チャネル、流通業者
・遺伝子組換え蛋白医薬品市場への影響要因分析
・遺伝子組換え蛋白医薬品の世界市場予測
・遺伝子組換え蛋白医薬品のアメリカ市場予測
・遺伝子組換え蛋白医薬品の中国市場予測
・遺伝子組換え蛋白医薬品のヨーロッパ市場予測
・遺伝子組換え蛋白医薬品の日本市場予測
・遺伝子組換え蛋白医薬品の東南アジア市場予測
・遺伝子組換え蛋白医薬品のインド市場予測
・遺伝子組換え蛋白医薬品の種類別世界市場予測
・遺伝子組換え蛋白医薬品の用途別世界市場予測
...

Notes:Sales, means the sales volume of Recombinant Protein Drugs
Revenue, means the sales value of Recombinant Protein Drugs

This report studies sales (consumption) of Recombinant Protein Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Novo Nordisk
Amgen
Sanofi
Eli Lilly
Merck Serono
Ortho Biotech
Roche
Kyowa Hakko Kirin
Pharmingen
Abcam
GenSci
SL PHARM
Dongbao Pharm
Ankebio
NCPC
Heng Rui

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Recombinant Protein Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Recombinant Protein Drugs in each application, can be divided into
Application 1
Application 2

レポート目次

Table of Contents

Global Recombinant Protein Drugs Sales Market Report 2017
1 Recombinant Protein Drugs Overview
1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Classification of Recombinant Protein Drugs
1.2.1 Type I
1.2.2 Type II
1.3 Application of Recombinant Protein Drugs
1.3.1 Application 1
1.3.2 Application 2
1.4 Recombinant Protein Drugs Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Recombinant Protein Drugs (2012-2022)
1.5.1 Global Recombinant Protein Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)

2 Global Recombinant Protein Drugs Competition by Manufacturers, Type and Application
2.1 Global Recombinant Protein Drugs Market Competition by Manufacturers
2.1.1 Global Recombinant Protein Drugs Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Recombinant Protein Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Recombinant Protein Drugs (Volume and Value) by Type
2.2.1 Global Recombinant Protein Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Recombinant Protein Drugs (Volume and Value) by Regions
2.3.1 Global Recombinant Protein Drugs Sales and Market Share by Regions (2012-2017)
2.3.2 Global Recombinant Protein Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Recombinant Protein Drugs (Volume) by Application

3 United States Recombinant Protein Drugs (Volume, Value and Sales Price)
3.1 United States Recombinant Protein Drugs Sales and Value (2012-2017)
3.1.1 United States Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Recombinant Protein Drugs Sales Price Trend (2012-2017)
3.2 United States Recombinant Protein Drugs Sales and Market Share by Manufacturers
3.3 United States Recombinant Protein Drugs Sales and Market Share by Type
3.4 United States Recombinant Protein Drugs Sales and Market Share by Application

4 China Recombinant Protein Drugs (Volume, Value and Sales Price)
4.1 China Recombinant Protein Drugs Sales and Value (2012-2017)
4.1.1 China Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Recombinant Protein Drugs Sales Price Trend (2012-2017)
4.2 China Recombinant Protein Drugs Sales and Market Share by Manufacturers
4.3 China Recombinant Protein Drugs Sales and Market Share by Type
4.4 China Recombinant Protein Drugs Sales and Market Share by Application

5 Europe Recombinant Protein Drugs (Volume, Value and Sales Price)
5.1 Europe Recombinant Protein Drugs Sales and Value (2012-2017)
5.1.1 Europe Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Recombinant Protein Drugs Sales Price Trend (2012-2017)
5.2 Europe Recombinant Protein Drugs Sales and Market Share by Manufacturers
5.3 Europe Recombinant Protein Drugs Sales and Market Share by Type
5.4 Europe Recombinant Protein Drugs Sales and Market Share by Application

6 Japan Recombinant Protein Drugs (Volume, Value and Sales Price)
6.1 Japan Recombinant Protein Drugs Sales and Value (2012-2017)
6.1.1 Japan Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Recombinant Protein Drugs Sales Price Trend (2012-2017)
6.2 Japan Recombinant Protein Drugs Sales and Market Share by Manufacturers
6.3 Japan Recombinant Protein Drugs Sales and Market Share by Type
6.4 Japan Recombinant Protein Drugs Sales and Market Share by Application
7 Southeast Asia Recombinant Protein Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Recombinant Protein Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Recombinant Protein Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Recombinant Protein Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Recombinant Protein Drugs Sales and Market Share by Type
7.4 Southeast Asia Recombinant Protein Drugs Sales and Market Share by Application
8 India Recombinant Protein Drugs (Volume, Value and Sales Price)
8.1 India Recombinant Protein Drugs Sales and Value (2012-2017)
8.1.1 India Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Recombinant Protein Drugs Sales Price Trend (2012-2017)
8.2 India Recombinant Protein Drugs Sales and Market Share by Manufacturers
8.3 India Recombinant Protein Drugs Sales and Market Share by Type
8.4 India Recombinant Protein Drugs Sales and Market Share by Application

9 Global Recombinant Protein Drugs Manufacturers Analysis
9.1 Novo Nordisk
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Recombinant Protein Drugs Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Amgen
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Recombinant Protein Drugs Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Sanofi
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Recombinant Protein Drugs Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Eli Lilly
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Recombinant Protein Drugs Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Merck Serono
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Recombinant Protein Drugs Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Ortho Biotech
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Recombinant Protein Drugs Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Roche
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Recombinant Protein Drugs Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Kyowa Hakko Kirin
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Recombinant Protein Drugs Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Pharmingen
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Recombinant Protein Drugs Product Type, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Abcam
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Recombinant Protein Drugs Product Type, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 GenSci
9.12 SL PHARM
9.13 Dongbao Pharm
9.14 Ankebio
9.15 NCPC
9.16 Heng Rui

10 Recombinant Protein Drugs Maufacturing Cost Analysis
10.1 Recombinant Protein Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Recombinant Protein Drugs
10.3 Manufacturing Process Analysis of Recombinant Protein Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Recombinant Protein Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Recombinant Protein Drugs Market Forecast (2017-2022)
14.1 Global Recombinant Protein Drugs Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Recombinant Protein Drugs Price and Trend Forecast (2017-2022)
14.2 Global Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Recombinant Protein Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Recombinant Protein Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Recombinant Protein Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Recombinant Protein Drugs
Table Classification of Recombinant Protein Drugs
Figure Global Sales Market Share of Recombinant Protein Drugs by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Recombinant Protein Drugs
Figure Global Sales Market Share of Recombinant Protein Drugs by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure China Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure India Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Figure Global Recombinant Protein Drugs Sales and Growth Rate (2012-2022)
Figure Global Recombinant Protein Drugs Revenue and Growth Rate (2012-2022)
Table Global Recombinant Protein Drugs Sales of Key Manufacturers (2012-2017)
Table Global Recombinant Protein Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Recombinant Protein Drugs Sales Share by Manufacturers
Figure 2016 Recombinant Protein Drugs Sales Share by Manufacturers
Table Global Recombinant Protein Drugs Revenue by Manufacturers (2012-2017)
Table Global Recombinant Protein Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Recombinant Protein Drugs Revenue Share by Manufacturers
Table 2016 Global Recombinant Protein Drugs Revenue Share by Manufacturers
Table Global Recombinant Protein Drugs Sales and Market Share by Type (2012-2017)
Table Global Recombinant Protein Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure Global Recombinant Protein Drugs Sales Growth Rate by Type (2012-2017)
Table Global Recombinant Protein Drugs Revenue and Market Share by Type (2012-2017)
Table Global Recombinant Protein Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by Type (2012-2017)
Figure Global Recombinant Protein Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Recombinant Protein Drugs Sales and Market Share by Regions (2012-2017)
Table Global Recombinant Protein Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Regions (2012-2017)
Figure Global Recombinant Protein Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Recombinant Protein Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Recombinant Protein Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Recombinant Protein Drugs by Regions (2012-2017)
Figure Global Recombinant Protein Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Recombinant Protein Drugs Sales and Market Share by Application (2012-2017)
Table Global Recombinant Protein Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Protein Drugs by Application (2012-2017)
Figure Global Recombinant Protein Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure United States Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure United States Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table United States Recombinant Protein Drugs Sales by Manufacturers (2012-2017)
Table United States Recombinant Protein Drugs Market Share by Manufacturers (2012-2017)
Table United States Recombinant Protein Drugs Sales by Type (2012-2017)
Table United States Recombinant Protein Drugs Market Share by Type (2012-2017)
Table United States Recombinant Protein Drugs Sales by Application (2012-2017)
Table United States Recombinant Protein Drugs Market Share by Application (2012-2017)
Figure China Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure China Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure China Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table China Recombinant Protein Drugs Sales by Manufacturers (2012-2017)
Table China Recombinant Protein Drugs Market Share by Manufacturers (2012-2017)
Table China Recombinant Protein Drugs Sales by Type (2012-2017)
Table China Recombinant Protein Drugs Market Share by Type (2012-2017)
Table China Recombinant Protein Drugs Sales by Application (2012-2017)
Table China Recombinant Protein Drugs Market Share by Application (2012-2017)
Figure Europe Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Europe Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Europe Recombinant Protein Drugs Sales by Manufacturers (2012-2017)
Table Europe Recombinant Protein Drugs Market Share by Manufacturers (2012-2017)
Table Europe Recombinant Protein Drugs Sales by Type (2012-2017)
Table Europe Recombinant Protein Drugs Market Share by Type (2012-2017)
Table Europe Recombinant Protein Drugs Sales by Application (2012-2017)
Table Europe Recombinant Protein Drugs Market Share by Application (2012-2017)
Figure Japan Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Japan Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Japan Recombinant Protein Drugs Sales by Manufacturers (2012-2017)
Table Japan Recombinant Protein Drugs Market Share by Manufacturers (2012-2017)
Table Japan Recombinant Protein Drugs Sales by Type (2012-2017)
Table Japan Recombinant Protein Drugs Market Share by Type (2012-2017)
Table Japan Recombinant Protein Drugs Sales by Application (2012-2017)
Table Japan Recombinant Protein Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Sales by Type (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Market Share by Type (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Sales by Application (2012-2017)
Table Southeast Asia Recombinant Protein Drugs Market Share by Application (2012-2017)
Figure India Recombinant Protein Drugs Sales and Growth Rate (2012-2017)
Figure India Recombinant Protein Drugs Revenue and Growth Rate (2012-2017)
Figure India Recombinant Protein Drugs Sales Price Trend (2012-2017)
Table India Recombinant Protein Drugs Sales by Manufacturers (2012-2017)
Table India Recombinant Protein Drugs Market Share by Manufacturers (2012-2017)
Table India Recombinant Protein Drugs Sales by Type (2012-2017)
Table India Recombinant Protein Drugs Market Share by Type (2012-2017)
Table India Recombinant Protein Drugs Sales by Application (2012-2017)
Table India Recombinant Protein Drugs Market Share by Application (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Recombinant Protein Drugs Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Recombinant Protein Drugs Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Recombinant Protein Drugs Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Recombinant Protein Drugs Global Market Share (2012-2017)
Table Merck Serono Basic Information List
Table Merck Serono Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Serono Recombinant Protein Drugs Global Market Share (2012-2017)
Table Ortho Biotech Basic Information List
Table Ortho Biotech Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ortho Biotech Recombinant Protein Drugs Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Recombinant Protein Drugs Global Market Share (2012-2017)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Global Market Share (2012-2017)
Table Pharmingen Basic Information List
Table Pharmingen Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pharmingen Recombinant Protein Drugs Global Market Share (2012-2017)
Table Abcam Basic Information List
Table Abcam Recombinant Protein Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abcam Recombinant Protein Drugs Global Market Share (2012-2017)
Table GenSci Basic Information List
Table SL PHARM Basic Information List
Table Dongbao Pharm Basic Information List
Table Ankebio Basic Information List
Table NCPC Basic Information List
Table Heng Rui Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2015
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure Global Recombinant Protein Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Recombinant Protein Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Recombinant Protein Drugs Sales Forecast by Regions (2017-2022)
Table Global Recombinant Protein Drugs Sales Forecast by Type (2017-2022)
Table Global Recombinant Protein Drugs Sales Forecast by Application (2017-2022)